Home » Antimicrobial Therapy for Life-Threatening Infections: Speed is Life – the Devastation of a Delayed Diagnosis
Antimicrobial Therapy for Life-Threatening Infections: Speed is Life – the Devastation of a Delayed Diagnosis
World Antimicrobial Resistance Congress Keynote
T2 Biosystems was featured in the World Antimicrobial Resistance Congress keynote presentation session. The plenary session highlighted the ability of the FDA-cleared T2Bacteria and T2Candida Panels to provide faster targeted therapy and support the critical aims of improved patient care and better antimicrobial stewardship.
Infectious disease expert and T2 customer Cornelius J. Clancy, M.D., University of Pittsburgh
Mary Millard, M. Ed., Patient Advocate, Sepsis Survivor
Thomas J. Lowery, Ph.D., Chief Scientific Officer, T2 Biosystems
T2 Biosystems, an emerging leader in the field of in vitro diagnostics, is dedicated to saving lives and reducing the cost of healthcare by empowering clinicians to effectively treat patients faster than ever before. T2 Biosystems is focused on addressing critical unmet needs in healthcare starting with sepsis, one of the deadliest and most expensive conditions in hospitals today.
The T2Dx Instrument, the T2Bacteria and T2Candida Panels have received marketing authorization from the U.S. Food and Drug Administration. All other T2 Biosystems products are considered investigational and for research use only.
T2 Biosystems®, T2MR®, T2Bacteria®, T2Candida®, and T2Dx® are registered trademarks of T2 Biosystems, Inc. “T2Biosystems” and the T2 Biosystems, Inc. logo design are registered trademarks or trademarks of T2Biosystems, Inc. All software and documentation is subject to T2 Biosystems, Inc. copyrights. All rights reserved. T2Direct Diagnostics™, T2HemoStat™, T2Plex™, T2Cauris™, T2Resistance™ and T2SARS-CoV-2™ are trademarks of T2 Biosystems, Inc.
Check out our latest #whitepaper containing clinical trial data, real-world evidence, and example algorithms that detail how T2Candida can be incorporated into practice and improve care for invasive candidiasis in your own practice.